<DOC>
	<DOCNO>NCT02641938</DOCNO>
	<brief_summary>To investigate renal protective effect dexmedetomidine patient undergoing cytoreduction hyperthermic intraperitoneal chemotherapy</brief_summary>
	<brief_title>Effect Intraoperative Dexmedetomidine Development Acute Kidney Injury</brief_title>
	<detailed_description>A cytoreductive surgery hyperthermic intraperitoneal chemotherapy may lead renal hypoperfusion , systemic inflammatory response , oxidative stress . Dexmedetomidine know protect kidney inflammation oxidative stress diverse clinical setting . It may also enhance renal perfusion inhibition renal sympathoexcitation . We hypothesize administration dexmedetomidine might protect kidney patient undergoing cytoreduction hyperthermic intraperitoneal chemotherapy .</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Diagnosis malignant tumor peritoneal metastasis Scheduled elective cytoreduction hyperthermic intraperitoneal chemotherapy Preoperative chronic kidney disease stage â‰¥4 define KDOQI ( eGFR &lt; 30 mL/min/1.73m2 ) Congestive heart failure Atrioventricular block &gt; 1st degree Bradycardia &lt; 45 beat per minute History myocardial infarction within 3 month Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>